Skip to main content

Table 1 Characteristics of subjects with and without obesity

From: Relationship of obesity and insulin resistance with the cerebrovascular reactivity: a case control study

 

Non-obese

Obese

P-valuea

(n = 85)

(n = 85)

Age, years

36 (26–44)

37 (27–44)

0.97a

Female, n (%)

68 (80)

68 (80)

1.00b

Anthropometric variables:

   

Weight, kg

58.6 (54–62.8)

107.4 (95.6-123.2)

<0.001a

Height, m

160 (156–168)

161 (154–167)

0.82a

BMI, kg/m2

22.9 (21.3-24.7)

41.2 (38.5-45)

<0.001a

Waist circumference, cm

76 (71–81.2)

117 (108.5-128)

<0.001a

Neck circumference, cm

31 (29–33)

40 (37.8-42)

<0.001a

Abdominal obesity, n (%)

15 (17)

84 (100)

<0.001b

Metabolic variables:

   

Fasting glucose, mg/dL

86 (80–91)

90 (83–97)

0.002a

Fasting insulin, mg/dL

7.3 (5.8-9.8)

19 (12.9-26.5)

<0.001a

HOMA-IR

1.6 (1.1-2.2)

4.4 (2.9-6)

<0.001a

Matsuda index

3.9 (2.2-6.3)

7.8 (5.2-11.1)

<0.001a

Glucose intolerance, n (%)

1 (1)

25 (29)

<0.001b

Triglycerides, mg/dL

95 (73–131)

138 (102–188.5)

<0.001a

Cholesterol, mg/dL

181 (164–203)

173.8 (152.8-201.5)

0.084a

HDL, mg/dL

53 (44–62)

42 (35–50)

<0.001a

LDL, mg/dL

109 (89.5-122)

101.4 (82.4-121.1)

0.23a

Metabolic syndrome, n (%)

2 (2)

33 (38)

<0.001b

OSA risk:

   

SACS, n (%)

0

4 (4)

0.121b

Epworth, n (%)

7 (8)

18 (21)

0.017b

  1. Data shown as n (%) or median (Inter Quartile Range). aMann-Whitney U test; b, x2, or Fisher exact test as appropriate. BMI, Body Mass Index (weight in kilograms/height in meters squared); HOMA-IR, Homeostasis Model Assessment- Insulin Resistance; LDL, Low Density Lipoprotein Cholesterol; HDL, High Density Lipoprotein Cholesterol; OSA, Obstructive Sleep Apnea; SACS, Sleep Apnea Clinical Scale.